These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Brain: positron emission tomography tracers beyond [¹⁸F]fluorodeoxyglucose. Singhal T; Alavi A; Kim CK PET Clin; 2014 Jul; 9(3):267-76. PubMed ID: 25030390 [TBL] [Abstract][Full Text] [Related]
4. [PET in neurology and psychiatry. II]. Trampal C; Engler H Rev Esp Med Nucl; 2002; 21(6):439-55; quiz 456-60. PubMed ID: 12425894 [No Abstract] [Full Text] [Related]
5. Clinical contribution of PET neurotransmission imaging in neurological disorders. Garraux G; Salmon E Acta Neurol Belg; 2005 Sep; 105(3):119-36. PubMed ID: 16255150 [TBL] [Abstract][Full Text] [Related]
6. Recent and future evolutions in NeuroSPECT with particular emphasis on the synergistic use and fusion of imaging modalities. d'Asseler YM; Koole M; Lemahieu I; Achten E; Boon P; De Deyn PP; Dierckx RA Acta Neurol Belg; 1997 Sep; 97(3):154-62. PubMed ID: 9345586 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography in the investigation of central nervous system disorders. Jamieson D; Alavi A; Jolles P; Chawluk J; Reivich M Radiol Clin North Am; 1988 Sep; 26(5):1075-88. PubMed ID: 3047777 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography as a diagnostic tool. A reassessment based on literature review. Shtern F Invest Radiol; 1992 Feb; 27(2):165-8. PubMed ID: 1601609 [TBL] [Abstract][Full Text] [Related]
12. Radiopharmaceuticals in positron emission tomography: present situation and future perspectives. Olivas Arroyo C Radiologia; 2016; 58(6):468-480. PubMed ID: 27592111 [TBL] [Abstract][Full Text] [Related]
13. Clinical applications of positron emission tomography. Maisey M; Jeffery P Br J Clin Pract; 1991; 45(4):265-72. PubMed ID: 1810361 [TBL] [Abstract][Full Text] [Related]
14. [Clinical applications of positron emission tomography]. Goldman S Rev Med Brux; 1993; 14(1-2):3-9. PubMed ID: 8438112 [TBL] [Abstract][Full Text] [Related]
15. [PET in clinical work. A refined instrument for imaging]. Långström B; Bergström K; Bergström M; Valind S Lakartidningen; 1995 Sep; 92(36):3203-13. PubMed ID: 7674712 [TBL] [Abstract][Full Text] [Related]
16. [PET and SPECT in epilepsy]. Setoain X; Carreño M; Pavía J; Martí-Fuster B; Campos F; Lomeña F Rev Esp Med Nucl Imagen Mol; 2014; 33(3):165-74. PubMed ID: 24565567 [TBL] [Abstract][Full Text] [Related]
17. [Positron emission tomography with FDG and newly developed tracers for the assessment of brain metabolism and synaptic function in neurological disorders]. Momose T Brain Nerve; 2007 May; 59(5):495-501. PubMed ID: 17533975 [TBL] [Abstract][Full Text] [Related]
18. Neuronuclear assessment of patients with epilepsy. Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079 [TBL] [Abstract][Full Text] [Related]
19. PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development. Sobrio F; Gilbert G; Perrio C; Barré L; Debruyne D Mini Rev Med Chem; 2010 Aug; 10(9):870-86. PubMed ID: 20504276 [TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]